Top Markets
Coin of the day
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Rang in Aktien #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-03-10
Marktkapitalisierung
$3.53K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel GeneThera, Inc. (GTHR)

Kategorie

Aktien-Split-Historie für GeneThera, Inc. (GTHR)
Die Aktie GeneThera, Inc. (Symbol: GTHR) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 12, 2026 statt.
Eine GTHR-Aktie, die vor dem Aug 12, 2026 gekauft wurde, entspricht heute 0 GTHR-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR